Impact of Ivabradine on renal function in septic patient with early renal impairment
Open Access
- 13 July 2021
- journal article
- research article
- Published by Egypts Presidential Specialized Council for Education and Scientific Research in Ain-Shams Journal of Anesthesiology
- Vol. 13 (1), 1-7
- https://doi.org/10.1186/s42077-021-00162-6
Abstract
Background Acute kidney injury (AKI) with sepsis increases mortality significantly. The pathophysiology of AKI during sepsis is complex and multifactorial. Lower heart rate is associated with better survival in patients with multiple organ dysfunction syndrome (MODS), a disease mostly caused by sepsis. In our study, we hypnotized that use of ivardrabine as heart rate reducing agent in septic patient with renal impairment may improve renal function. Results Fifty patients with sepsis with early renal impairment were divided in 1: 1 ratio to receive Ivabradine (group I) or not (group C). The average age of the included patients was almost 45 years, chest disorders were the main cause of sepsis in both groups. There were statistically significant differences between both groups in terms of reduction of heart rate group (I) (68.13 ± 3.34) versus (group C) (87.04 ± 3.23) and (P < 0.001) also, improvement in eGFR by Cystatin c in group (I) (103.32 ± 6.96) versus (group C) (96.25 ± 6.36) and (P < 0.001) also vasopressor dosage consumption (P < 0.001). As regards secondary outcomes, there were no statistically significant differences between study’s groups in terms of length of hospital stay (P = 0.390), need for hemodialysis (P = 0.384), and mortality (P = 1.000). Conclusions We concluded that Ivabradine as an adjuvant therapy in septic patients with renal impairment is promising agent to reduce such impairment. Trial registration Pan African Clinical Trial Registry: Identification number for the registry is PACTR201911806644230.Keywords
This publication has 15 references indexed in Scilit:
- Ivabradine Attenuates the Microcirculatory Derangements Evoked by Experimental SepsisAnesthesiology, 2017
- Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndromeClinical Research in Cardiology, 2014
- Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic ShockJAMA, 2013
- Epidemiology of septic acute kidney injury.Current Drug Targets, 2009
- Pathophysiology of septic acute kidney injury: What do we really know?Critical Care Medicine, 2008
- Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care unitsCritical Care, 2007
- Cystatin C as a Marker of Renal Function in Critically Ill Patients at Risk for or with Acute Renal FailureYearbook of Intensive Care and Emergency Medicine, 2007
- Acute Renal Failure and SepsisThe New England Journal of Medicine, 2004
- Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) GroupCritical Care, 2004
- Cystatin C-Properties and use as diagnostic markerAdvances in clinical chemistry, 2001